At the news
? NEUTRALIMPACT 5/10 8-K filed Nov 4, 2026 at 16:18 ET
The company reaffirmed its full-year 2026 revenue guidance of $390M-$410M and its adjusted EBITDA loss guidance of $35M-$30M, while U.S. procedure growth of 22% and handpiece ASP increases of 12% showed positive operational trends.
- Q3 2026 total revenue $98.3M, up 18% YoY from $83.3M
- U.S. procedures over 13,400, up approximately 22% YoY
- U.S. handpiece ASP approximately $3,570, up 12% YoY
- International revenue $12.5M, up 32% YoY
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access